PSIL Holdings Information

PSIL is an equity ETF with a total of 28 individual holdings. The top holdings are Atai Life Sciences stock at 15.93%, COMPASS Pathways at 8.04%, Mind Medicine (MindMed) at 7.75%, NRx Pharmaceuticals at 6.02%, and Relmada Therapeutics at 4.78%.

Total Holdings

Top 10 Percentage

64.91%

Asset Class

Equity

ETF Category

Miscellaneous Sector

Assets

17.15M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ATAI	Atai Life Sciences N.V.	15.93%	478,331
2	CMPS	COMPASS Pathways plc	8.04%	219,505
3	MNMD	Mind Medicine (MindMed) Inc.	7.75%	114,944
4	NRXP	NRx Pharmaceuticals, Inc.	6.02%	323,226
5	RLMD	Relmada Therapeutics, Inc.	4.78%	418,038
6	GHRS	GH Research PLC	4.65%	51,001
7	CSE: DRUG	Bright Minds Biosciences Inc.	4.50%	13,519
8	NEUP	Neuphoria Therapeutics Inc.	4.44%	57,023
9	TTTXX	BlackRock Treasury Trust Fund	4.43%	701,315
10	VTGN	Vistagen Therapeutics, Inc.	4.36%	195,558
11	SUPN	Supernus Pharmaceuticals, Inc.	4.36%	14,665
12	ALKS	Alkermes plc	4.27%	24,229
13	NBIX	Neurocrine Biosciences, Inc.	4.22%	4,702
14	NEO: CYBN	Cybin Inc.	4.06%	109,682
15	JNJ	Johnson & Johnson	3.86%	3,400
16	CSE: QNTM	Quantum BioPharma Ltd.	3.63%	35,177
17	STIM	Neuronetics, Inc.	3.08%	179,605
18	SILO	Silo Pharma, Inc.	1.70%	344,708
19	IXHL	Incannex Healthcare Inc.	1.67%	445,238
20	CMND	Clearmind Medicine Inc.	1.41%	211,978
21	KTTA	Pasithea Therapeutics Corp.	1.12%	243,456
22	TSX: NUMI	Numinus Wellness Inc.	0.84%	3,866,502
23	ENVB	Enveric Biosciences, Inc.	0.78%	203,679
24	PBM	Psyence Biomedical Ltd.	0.10%	5,078
25	n/a	Cash	0.00%	1

Showing 25 of 28 holdings

Subscribe to see the full list

Upgrade Now

As of Sep 26, 2025